Collectively, patient-anchored, promoter-targeted genome editing can potentially correct pathogenic PMP22 dosage while preserving basal expression, establishing a translational iPSC-based framework for treating dosage-sensitive demyelinating neuropathies such as CMT1A.
Current evidence on the genetic, molecular, and regulatory architecture of CMT1A is synthesized, with particular emphasis on distal regulatory elements controlling PMP22 expression, promoter-specific transcriptional regulation, and mechanisms contributing to phenotypic heterogeneity, support an increasingly individuali...
Yousef VatanParast· Egyptian Journal of Medical...· 0 citations
The selection of L-CMD iPSCs is expanded, disease-associated readouts are validated using a transgene-free differentiation protocol and gene editing strategies are assessed using 2D and 3D cultures, providing an advanced, humanised platform for translational research and precision medicine in laminopathies.
D. Moore, H. Steele-Stallard, Luca Pinton et al.· Molecular Therapy· 0 citations
Patient iPSC-differentiated NCC and OPC lines, combined with TAD-based modelling to generate testable functional hypotheses, provide valuable functional evidence when evaluating causation of unique SV/CNV in craniosynostosis.
D. Korona, Akiko Hashimoto, Yang Pei et al.· Genetics in Medicine· 0 citations
ABSTRACT Background The SLC25A38 is one of the genes of the heme biosynthesis pathway and disruptive alterations therein cause autosomal recessive congenital sideroblastic anemia (CSA). Primary patient‐derived fibroblasts can be used as a valuable source for disease modeling, cell therapy studies, and the generation of...
S. Yazdanparast, H. Galehdari, S. Khatami et al.· Journal of Gene Medicine· 0 citations
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration and respiratory failure. Approximately 10% of ALS cases are familial, with mutations in
SOD1
representing a major genetic cause. Preservation of physiological SOD1 function may be i...
K. Imamura, Kayoko Tsukita, Shin Yoshioka et al.· BMC Medical Genomics· 0 citations
BACKGROUND
Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular disease caused by mutations in the DMD gene, leading to the absence or dysfunction of dystrophin. Although cardiac and skeletal muscles are both affected, tissue-specific differences in disease manifestation and dystrophin regulation remain...
M. Białobrzeska, M. Przymuszała, Paweł E. Ferdek et al.· Circulation Genomic and Prec...· 0 citations